Acasti Pharma reported $0 in Cost of Sales for its fiscal quarter ending in March of 2022.





Cost Of Sales Change Date
Addus HomeCare USD 253.62M 3.63M Dec/2025
Amarin USD 16.89M 18.51M Mar/2025
Cassava Sciences USD 3.96M 1.16M Sep/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Option Care Health USD 1.2B 23.4M Dec/2025
Organigram Holdings CAD 77.46M 14.63M Sep/2025
Tilray USD 164.37M 8.41M Sep/2025